QQQ   425.84 (-1.22%)
AAPL   168.00 (-0.81%)
MSFT   411.84 (-0.66%)
META   494.17 (-1.12%)
GOOGL   155.47 (+0.69%)
AMZN   181.28 (-1.11%)
TSLA   155.45 (-1.06%)
NVDA   840.35 (-3.87%)
AMD   154.02 (-5.78%)
NIO   3.91 (+2.62%)
BABA   68.82 (-1.13%)
T   16.12 (+0.19%)
F   12.04 (-0.41%)
MU   116.33 (-4.47%)
GE   155.67 (-0.70%)
CGC   6.49 (-3.13%)
DIS   112.94 (-0.83%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.26 (-0.27%)
XOM   118.63 (-0.05%)
QQQ   425.84 (-1.22%)
AAPL   168.00 (-0.81%)
MSFT   411.84 (-0.66%)
META   494.17 (-1.12%)
GOOGL   155.47 (+0.69%)
AMZN   181.28 (-1.11%)
TSLA   155.45 (-1.06%)
NVDA   840.35 (-3.87%)
AMD   154.02 (-5.78%)
NIO   3.91 (+2.62%)
BABA   68.82 (-1.13%)
T   16.12 (+0.19%)
F   12.04 (-0.41%)
MU   116.33 (-4.47%)
GE   155.67 (-0.70%)
CGC   6.49 (-3.13%)
DIS   112.94 (-0.83%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.26 (-0.27%)
XOM   118.63 (-0.05%)
QQQ   425.84 (-1.22%)
AAPL   168.00 (-0.81%)
MSFT   411.84 (-0.66%)
META   494.17 (-1.12%)
GOOGL   155.47 (+0.69%)
AMZN   181.28 (-1.11%)
TSLA   155.45 (-1.06%)
NVDA   840.35 (-3.87%)
AMD   154.02 (-5.78%)
NIO   3.91 (+2.62%)
BABA   68.82 (-1.13%)
T   16.12 (+0.19%)
F   12.04 (-0.41%)
MU   116.33 (-4.47%)
GE   155.67 (-0.70%)
CGC   6.49 (-3.13%)
DIS   112.94 (-0.83%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.26 (-0.27%)
XOM   118.63 (-0.05%)
QQQ   425.84 (-1.22%)
AAPL   168.00 (-0.81%)
MSFT   411.84 (-0.66%)
META   494.17 (-1.12%)
GOOGL   155.47 (+0.69%)
AMZN   181.28 (-1.11%)
TSLA   155.45 (-1.06%)
NVDA   840.35 (-3.87%)
AMD   154.02 (-5.78%)
NIO   3.91 (+2.62%)
BABA   68.82 (-1.13%)
T   16.12 (+0.19%)
F   12.04 (-0.41%)
MU   116.33 (-4.47%)
GE   155.67 (-0.70%)
CGC   6.49 (-3.13%)
DIS   112.94 (-0.83%)
AMC   2.98 (+9.56%)
PFE   25.42 (-1.05%)
PYPL   63.26 (-0.27%)
XOM   118.63 (-0.05%)

Rapid Micro Biosystems (RPID) Competitors

$0.94
+0.00 (+0.51%)
(As of 04:28 PM ET)

RPID vs. OMIC, HLTH, BNGO, TLIS, TBIO, DTIL, SEER, CASI, VIRX, and RFL

Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include Singular Genomics Systems (OMIC), Cue Health (HLTH), Bionano Genomics (BNGO), Talis Biomedical (TLIS), Telesis Bio (TBIO), Precision BioSciences (DTIL), Seer (SEER), CASI Pharmaceuticals (CASI), Viracta Therapeutics (VIRX), and Rafael (RFL). These companies are all part of the "medical" sector.

Rapid Micro Biosystems vs.

Singular Genomics Systems (NASDAQ:OMIC) and Rapid Micro Biosystems (NASDAQ:RPID) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership, community ranking and valuation.

Singular Genomics Systems received 9 more outperform votes than Rapid Micro Biosystems when rated by MarketBeat users. Likewise, 48.15% of users gave Singular Genomics Systems an outperform vote while only 26.67% of users gave Rapid Micro Biosystems an outperform vote.

CompanyUnderperformOutperform
Singular Genomics SystemsOutperform Votes
13
48.15%
Underperform Votes
14
51.85%
Rapid Micro BiosystemsOutperform Votes
4
26.67%
Underperform Votes
11
73.33%

Rapid Micro Biosystems has higher revenue and earnings than Singular Genomics Systems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Singular Genomics Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Singular Genomics Systems$2.91M10.10-$94.82M-$1.31-0.30
Rapid Micro Biosystems$22.52M1.77-$52.47M-$1.22-0.77

Singular Genomics Systems presently has a consensus price target of $0.68, indicating a potential upside of 69.81%. Given Rapid Micro Biosystems' higher probable upside, analysts clearly believe Singular Genomics Systems is more favorable than Rapid Micro Biosystems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Singular Genomics Systems
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Rapid Micro Biosystems
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Singular Genomics Systems had 2 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 2 mentions for Singular Genomics Systems and 0 mentions for Rapid Micro Biosystems. Singular Genomics Systems' average media sentiment score of 0.16 beat Rapid Micro Biosystems' score of 0.00 indicating that Rapid Micro Biosystems is being referred to more favorably in the news media.

Company Overall Sentiment
Singular Genomics Systems Neutral
Rapid Micro Biosystems Neutral

Singular Genomics Systems has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.

Rapid Micro Biosystems has a net margin of -232.99% compared to Rapid Micro Biosystems' net margin of -3,257.30%. Singular Genomics Systems' return on equity of -39.02% beat Rapid Micro Biosystems' return on equity.

Company Net Margins Return on Equity Return on Assets
Singular Genomics Systems-3,257.30% -45.33% -33.29%
Rapid Micro Biosystems -232.99%-39.02%-33.43%

65.8% of Singular Genomics Systems shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 22.6% of Singular Genomics Systems shares are held by company insiders. Comparatively, 32.4% of Rapid Micro Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Singular Genomics Systems beats Rapid Micro Biosystems on 9 of the 16 factors compared between the two stocks.

Get Rapid Micro Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPID vs. The Competition

MetricRapid Micro BiosystemsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$39.95M$5.35B$4.74B$7.41B
Dividend YieldN/A0.39%5.40%3.96%
P/E Ratio-0.779.66220.8616.25
Price / Sales1.775.312,428.3187.67
Price / CashN/A42.5047.4735.32
Price / Book0.343.834.604.21
Net Income-$52.47M-$9.41M$101.28M$211.53M
7 Day Performance-2.08%-8.48%-4.64%-4.35%
1 Month Performance-4.08%-10.70%-4.34%-3.37%
1 Year Performance-11.74%-19.36%10.56%4.59%

Rapid Micro Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMIC
Singular Genomics Systems
1.8247 of 5 stars
$0.46
-6.1%
$0.68
+46.4%
-62.1%$34.10M$2.91M-0.35284Gap Up
HLTH
Cue Health
2.8776 of 5 stars
$0.18
flat
$3.00
+1,605.5%
-91.1%$27.88M$64.22M-0.07726News Coverage
Gap Up
BNGO
Bionano Genomics
1.1755 of 5 stars
$1.05
-0.9%
$21.33
+1,931.7%
-92.2%$57.42M$36.12M-0.16344Gap Up
TLIS
Talis Biomedical
0.4885 of 5 stars
$8.35
+0.7%
$5.00
-40.1%
+21.7%$15.20M$2.13M-0.24102Positive News
TBIO
Telesis Bio
0 of 5 stars
$0.43
flat
N/A-88.0%$12.95M$27.51M-0.26223Positive News
Gap Up
DTIL
Precision BioSciences
3.7524 of 5 stars
$13.84
+2.3%
$60.00
+333.5%
-49.2%$95.77M$48.73M-0.86115Analyst Report
Gap Down
SEER
Seer
2.019 of 5 stars
$1.76
+1.7%
$7.00
+297.7%
-55.1%$114.00M$16.66M-1.29147
CASI
CASI Pharmaceuticals
3.9861 of 5 stars
$3.13
+0.6%
$12.00
+283.4%
-37.3%$41.95M$33.88M-1.55224Gap Down
VIRX
Viracta Therapeutics
1.7821 of 5 stars
$1.06
-0.9%
$5.00
+371.7%
-51.0%$41.63MN/A-0.8040Analyst Report
News Coverage
Gap Up
RFL
Rafael
0 of 5 stars
$1.69
-2.3%
N/A-6.7%$41.54M$280,000.0016.9013News Coverage

Related Companies and Tools

This page (NASDAQ:RPID) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners